Ilkos Therapeutic Inc. Report issue

For profit Phase 1 Phase 2
Founded: Laval Canada (2016)
Status: Acquired by Odan Laboratories Ltd (2021)

Organization Overview

First Clinical Trial
2016
NCT04214665
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Ilko Ilac San. ve Tic. A.S.

Active Ingredients

Drugs in Phase 2 Trials (1)

s42909 (1 trial)

Drugs in Phase 1 Trials (1)

alpha-lipoic acid (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetic Neuropathies (Phase 1)

Leg Ulcer (Phase 2)

Polyneuropathies (Phase 1)

Ulcer (Phase 2)

Varicose Ulcer (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 2